Taysha Gene Therapies, Inc.
TSHA
$6.85
$0.030.44%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 276.58M | 319.77M | 297.34M | 312.76M | 116.59M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.46M | 974.00K | 806.00K | 495.00K | 2.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.21M | 3.91M | 1.80M | 3.01M | 2.05M |
| Total Current Assets | 282.25M | 324.65M | 299.95M | 316.26M | 120.71M |
|
|
|||||
| Total Current Assets | 282.25M | 324.65M | 299.95M | 316.26M | 120.71M |
| Net Property, Plant & Equipment | 15.61M | 16.18M | 14.27M | 14.73M | 15.32M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.50M | 2.50M | 2.34M | 2.34M | 2.34M |
| Total Assets | 300.35M | 343.32M | 316.55M | 333.33M | 138.36M |
|
|
|||||
| Total Accounts Payable | 4.56M | 6.28M | 5.44M | 7.71M | 4.33M |
| Total Accrued Expenses | 12.93M | 17.62M | 14.39M | 9.00M | 7.81M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.82M | 1.87M | 1.67M | 1.74M | 1.81M |
| Total Finance Division Other Current Liabilities | 784.00K | 796.00K | 7.14M | 6.89M | 8.61M |
| Total Other Current Liabilities | 784.00K | 796.00K | 7.14M | 6.89M | 8.61M |
| Total Current Liabilities | 20.10M | 26.55M | 28.63M | 25.35M | 22.56M |
|
|
|||||
| Total Current Liabilities | 20.10M | 26.55M | 28.63M | 25.35M | 22.56M |
| Long-Term Debt | 48.96M | 50.11M | 50.85M | 41.05M | 42.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.77M | 18.17M | 16.56M | 16.98M | 17.37M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.58M | 1.55M | 1.52M | 1.23M | 925.00K |
| Total Liabilities | 88.41M | 96.38M | 97.57M | 84.60M | 83.30M |
|
|
|||||
| Common Stock & APIC | 964.67M | 958.43M | 903.58M | 900.14M | 681.18M |
| Retained Earnings | -753.71M | -711.30M | -683.45M | -650.72M | -623.83M |
| Treasury Stock & Other | 985.00K | -192.00K | -1.14M | -699.00K | -2.29M |
| Total Common Equity | 211.94M | 246.94M | 218.99M | 248.73M | 55.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 211.94M | 246.94M | 218.99M | 248.73M | 55.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 211.94M | 246.94M | 218.99M | 248.73M | 55.06M |
|
|
|||||